BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32127225)

  • 1. The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.
    Shu J; Shen W; Liu H; Zhou Y; Li J; Zhuang Y; Huang Z; Yin S; Jiang L; Sun Y; Jin X; Xu J
    Vaccine; 2020 Mar; 38(14):2913-2924. PubMed ID: 32127225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
    Oyarzún P; Ellis JJ; Bodén M; Kobe B
    BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
    Ribeiro SP; De Moura Mattaraia VG; Almeida RR; Valentine EJG; Sales NS; Ferreira LCS; Sa-Rocha LC; Jacintho LC; Santana VC; Sidney J; Sette A; Rosa DS; Kalil J; Cunha-Neto E
    Vaccine; 2022 Jan; 40(2):239-246. PubMed ID: 34961636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
    Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
    Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens.
    Reguzova A; Antonets D; Karpenko L; Ilyichev A; Maksyutov R; Bazhan S
    PLoS One; 2015; 10(3):e0116412. PubMed ID: 25786238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
    Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
    Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.
    Reynolds CJ; Jones C; Blohmke CJ; Darton TC; Goudet A; Sergeant R; Maillere B; Pollard AJ; Altmann DM; Boyton RJ
    Immunology; 2014 Nov; 143(3):438-46. PubMed ID: 24891088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.
    Liu J; Ewald BA; Lynch DM; Nanda A; Sumida SM; Barouch DH
    J Virol; 2006 Dec; 80(24):11991-7. PubMed ID: 17005652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
    Rosendahl Huber SK; Luimstra JJ; van Beek J; Hoppes R; Jacobi RH; Hendriks M; Kapteijn K; Ouwerkerk C; Rodenko B; Ovaa H; de Jonge J
    PLoS One; 2016; 11(6):e0156462. PubMed ID: 27333291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments.
    Roider J; Meissner T; Kraut F; Vollbrecht T; Stirner R; Bogner JR; Draenert R
    Immunology; 2014 Oct; 143(2):193-201. PubMed ID: 24724694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell epitope prediction using antigen processing constraints.
    Mettu RR; Charles T; Landry SJ
    J Immunol Methods; 2016 May; 432():72-81. PubMed ID: 26891811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promiscuous
    Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
    Front Immunol; 2019; 10():207. PubMed ID: 30828331
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles.
    Mertz AK; Wu P; Sturniolo T; Stoll D; Rudwaleit M; Lauster R; Braun J; Sieper J
    J Immunol; 2000 Feb; 164(3):1529-37. PubMed ID: 10640771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.